TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray December 13, 2002
TCL Archive NCI advisors approved a proposal to set aside $75 million over the next five years to fund centers to study nutrition, energy balance, and physical activity. Also Board approves concepts for Cancer Disparities Networks, research in palliative care, and career awards for quantitative scientists. December 5, 2003
